References
- World Health OrganizationGlobal Tuberculosis Report 2015Geneva, SwitzerlandWorld Health Organization2015
- BothamleyGLipmanMKonOMCavitating pulmonary tuberculosis: a global challengeClin Med2012123 299
- ReichmanLBHershfieldESTuberculosis – A Comprehensive International ApproachYale J Biol Med1992664 192
- YoderMALamichhaneGBishaiWRCavitary pulmonary tuberculosis: the holy grail of disease transmissionCurr Sci2004861 74 81
- BenatorDBhattacharyaMBozemanLRifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trialLancet20023609332 528 53412241657
- AristoffPAGarciaGAKirchhoffPDShowalterHDRifamycins – obstacles and opportunitiesTuberculosis2010902 94 11820236863
- Der LippeBVSandvenPBrubakkOEfficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) – a report of ten casesJ Infect2006522 92 9615907341
- YiLYoshiyamaTOkumuraMLinezolid as a potentially effective drug for the treatment of multidrug-resistant tuberculosis in JapanJpn J Infect Dis Epub2016318
- LeeMLeeJCarrollMWLinezolid for treatment of chronic extensively drug-resistant tuberculosisN Engl J Med201236716 1508 151823075177
- AsteteCESabliovCMSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polym Ed2006173 247 28916689015
- YuanZGuXPreparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral deliveryDrug Des Devel Ther20159 2301 2309
- ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev1997281 5 2410837562
- HuCFengHZhuCPreparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery systemColloids Surf B: Biointerfaces201295 162 169
- WuJZuoYHuYJDevelopment and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosisDrug Des Devel Ther20159 1359 1366
- WeberAOpheimKESmithALWongKHigh-pressure liquid chromatographic quantitation of rifampin and its two major metabolites in urine and serumRev Infect Dis19835Suppl 3 S433 S4396635434
- LigginsRTBurtHMPaclitaxel loaded poly(L-lactic acid)(PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kineticsInt J Pharm20042811−2 103 10615288347
- Malaekeh-NikoueiBSajadi TabassiSAJaafariMRThe effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine ACurr Drug Deliv200634 343 34917076635
- YangCPlackettDNeedhamDBurtHMPLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infectionsPharm Res2009267 1644 165619384471
- GilchristSERickardDLLetchfordKNeedhamDBurtHMPhase separation behavior of fusidic acid and rifampicin in PLGA microspheresMol Pharm201295 1489 150122482935
- YeoYParkKControl of encapsulation efficiency and initial burst in polymeric microparticle systemsArch Pharm Res2004271 1 1214969330
- MehtaRCThanooBCDeLucaPPPeptide containing microspheres from low molecular weight and hydrophilic poly (d,l-lactide-co-glycolide)J Control Release1996413 249 257
- BouryFMarchaisHProustJEBenoitJPBovine serum albumin release from poly(α-hydroxy acid) microspheres: effects of polymer molecular weight and surface propertiesJ Control Release1997451 75 86
- AllisonSDAnalysis of initial burst in PLGA microparticlesExpert Opin Drug Deliv200856 615 62818532918
- JanoriaKGMitraAKEffect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheresInt J Pharm20073381–2 133 14117363204